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Abstract: Ultra-small nanoparticles with sizes comparable to those of pores in the cellular membrane
possess significant potential for application in the field of biomedicine. Silicon carbide ultra-small
nanoparticles with varying surface termination were tested for the biological system represented
by different human cells (using a human osteoblastic cell line as the reference system and a
monocyte/macrophage cell line as immune cells). The three tested nanoparticle surface terminations
resulted in the observation of different effects on cell metabolic activity. These effects were mostly
noticeable in cases of monocytic cells, where each type of particle caused a completely different
response (‘as-prepared’ particles, i.e., were highly cytotoxic, –OH terminated particles slightly
increased the metabolic activity, while –NH2 terminated particles caused an almost doubled metabolic
activity) after 24 h of incubation. Subsequently, the release of cytokines from such treated monocytes
and their differentiation into activated cells was determined. The results revealed the potential
modulation of immune cell behavior following stimulation with particular ultra-small nanoparticles,
thus opening up new fields for novel silicon carbide nanoparticle biomedical applications.
Keywords: nanoparticles; silicon carbide; cytotoxicity; immune cells; osteoblasts
1. Introduction
The knowledge of nanoparticles (NPs) and their potential application in the field of biomedicine as
drug delivery [1,2], therapeutic [3–5], and diagnostic platforms and imaging devices [6] have improved
significantly over recent years. While particles of different materials and sizes have been studied in
detail, only a limited numbers of studies on ultra-small NPs, with sizes of less than 5 nm, have been
reported [7–9]. Ultra-small silicon carbide NPs, the study of which remains exceptional, are particularly
interesting not only due to their biocompatibility and biodegradability [10–12] but also due to their
extremely small size (approximately 4 nm). The potential use of such particles in biomedicine is,
however, only partially understood; only a small number of isolated studies taking advantage of their
natural fluorescence have been conducted to date [11,13,14]. Moreover, the differing surface termination
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of otherwise identical NPs is of particular interest due to the potential for further modification and
cluster formation as well as in terms of their influence on the overall cellular response [15–18].
As soon as any NP is administered into a biological fluid (a cultivation medium in vitro or blood
in vivo), the particles form a new identity from the various components of the surrounding environment
that is widely known as the biomolecular or protein corona (PC) since it is formed by biomolecules and,
principally, by proteins [19]. This new identity then serves as a particle-cell interaction mediator [20–22].
While in in vivo experiments the PC is present constantly and changes over time, the interaction of NPs
with cells in vitro can also be tested without the PC (incubation in the medium without fetal bovine
serum (FBS) supplementation) which may assist in the understanding of the impact of the NP material
itself. Naturally, the commonly presented PC concept cannot be applied in the case of ultra-small NPs
since they are mostly of the same size or smaller than the individual components (proteins) that usually
form the corona; however, their interaction with FBS proteins should not be overlooked [23].
Any application conducted in vivo should be preceded by a complex study of NP–cell interaction
in vitro that must not only take into account the response of tissue-specific cells but also include a broader
view of the future administration of the particles into living organisms (e.g., ingestion, inhalation, or
intravenous application). Regardless of the administration method, immune cells are likely to be the
first type of cells to respond to the presence of NPs in the body since their purpose is to find and
react with foreign agents. The method used to introduce NPs into the living organism determines
the types of immune cells that respond—monocytes (cells freely circulating in the blood), dendritic
cells (cells mostly found in diverse epithelia), or macrophages (tissue-specific cells). Numerous studies
have been conducted regarding the influence of various NPs on the immune cell metabolism, the
mitochondrial state, and overall viability [24,25], as well as their response to allergic and inflammatory
reactions [26–28]. Such data is able to assist in both revealing the potential cytotoxicity of NPs and
elucidating the mechanisms via which NPs influence cells. Although NPs are viewed primarily as
simple carriers, recent studies have reported their immunomodulating properties [5,29–31].
Herein, three size-identical ultra-small silicon carbide (SiC-based) NPs varying only in their surface
termination—NPs as prepared (SiC–x), NPs with NH2 groups (SiC–NH2) and NPs with OH groups
(SiC–OH) on their surface—were studied in the scope of the biological environment. These NPs are
shown to have a different impact on various cell types (osteoblasts, monocytes, and macrophages).
Influence on the cellular metabolic activity as well as on the state of mitochondria and production of
cytokines in short term cultivation is shown with respect to immune cells, indicating the possibilities for
further applications of such NPs and showing the crucial importance of surface termination of such NPs.
2. Materials and Methods
2.1. Nanoparticle Preparation and Characterization
SiC nanocrystals were prepared via the wet chemical etching method, as reported previously [32,33].
The particles were then terminated with a variety of oxygen-containing species with a high concentration
of carboxyl groups [33]. The preparation of the OH-terminated nanoparticles (SiC–OH) involved the
reduction of SiC–x NPs via NaBH4 in an aqueous solution [34]. The SiC–OH were then silanized for the
preparation of the SiC–NH2 particles. Briefly, after changing the solvent from deionized water to ethanol
with a 1kDa Pall Macrosep ( Pall Co., New York, NY, USA) filter, 10 µL/mL of (APDMES, Sigma-Aldrich,
St. Louis, MO, USA) was added to the solution at 40 ◦C for 2 h. The excess reactant was removed,
and the solvent was changed back to DI water with a 1kDa Pall Macrosep filter. Size distribution of
NPs was measured by means of atomic force microscopy (AFM, Bruker Dimension Icon atomic force
microscope using Bruker (Bruker, Palaiseau, France) Tapping mode and Bruker MPP-11100-10 probe
(Bruker, Palaiseau, France), Pall Macrosep). Fourier transform infrared spectra (FTIR) was measured
using Bruker Tensor37 (Bruker Co., Billerica, MA, USA) spectrometer equipped with a zinc selenide
horizontal multi bounce attenuated total internal reflection accessory, and nuclear magnetic resonance
spectra (NMR) was measured using Varian NMR System (Varian, Palo Alto, CA, USA), 600 MHz.
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2.2. Zeta Potential Determination
The zeta potential (ζ) of the SiC-based NPs was determined in water (standard solution), DMEM
and RPMI 1640 media as well as in both the media with the addition of 5% FBS. The differing NPs in
the same amount were pre-incubated overnight in the respective solutions under constant rotation at
room temperature (RT). The NPs were centrifuged at 13,000 g for 30 min at RT. The pellet was washed
in phosphate buffer saline (PBS) and centrifuged; the process was repeated six times. The final pellet
was resuspended in 100 µL of PBS and subsequently diluted with distilled water to achieve a maximal
conductivity of 1.5 mS/cm and measured immediately. The ζ was measured using a Zetasizer Nano
Series and software Malvern Zetasizer software ver. 7.13 (Malvern Pananalytical Ltd., Malvern, UK).
2.3. Cell Culture
The human osteoblastic cell line (SAOS-2, DSMZ, Braunschweig, Germany) was cultured in
McCoy’s 5 A medium (GE Healthcare – HyClone, Sigma-Aldrich, St. Louis, MO, USA) supplemented
with 15% FBS (Biosera, Nuaille, France), L-glutamine (Life Technologies, Thermo Fischer Scientific,
Waltham, MA, USA), 10,000 U/mL of penicillin and 10 µg/mL of streptomycin (both Sigma-Aldrich,
St. Louis, MO, USA) in a CO2 humidified incubator at 37 ◦C. The human monocytic cell line (suspension,
THP-1, ATCC) was cultured in RPMI 1640 medium (Biowest, Nuaillé, France) supplemented with 10%
FBS (Biosera, Nuaille, France), L-glutamine (Life Technologies, Thermo Fischer Scientific, Waltham,
MA, USA), 10,000 U/mL of penicillin and 10 µg/mL of streptomycin (both Sigma-Aldrich, St. Louis, MO,
USA). The differentiation of the suspension monocytic THP-1 cells into adherent macrophage-like cells
was performed via the following method. The cells were seeded at a concentration of 160,000 cells/cm2
on 6-well plate and cultivated for 72 h in a standard cultivation medium supplemented with 1 µM of
phorbol 12-myristate13- acetate (PMA, Sigma-Aldrich, St. Louis, MO, USA). The adherent THP-1 were
then trypsinized and used for further experiments. The differentiation of the suspension monocytes into
dendritic-like cells was induced via the cultivation of the cells in 2 ml of standard cultivation medium
supplemented with 0.1 µg/mL of GM-CSF and 0.1 µg/mL of IL-4 (both Thermo Fischer Scientific,
Waltham, MA, USA) for 72 h, whereupon 1 ml of fresh standard cultivation medium supplemented
with GM-CSF and IL-4 was added followed by cultivation for further 48 h (5 days of treatment in total).
2.4. Metabolic Activity Determination
The adherent cells were pre-seeded in the respective standard cultivation medium at a concentration
of 10,000 cells/cm2 in 96-well plates for 24 h. The cells were then washed with pre-warmed PBS and
the NPs (25, 50, and 100 µg/mL) in the corresponding medium (DMEM for SAOS-2 and RPMI 1640
for adherent THP-1), supplemented with 5% FBS or non-FBS-supplemented, were added to the cells;
corresponding blanks were also prepared (only the medium with the NPs). After 6 h, the medium
with the NPs was replaced with the corresponding NP-free medium supplemented with 5% FBS and
cultivation continued up to 24 h. The medium was then discarded and fresh medium with 10% MTS
solution was added to the wells. MTS colorimetric assay (Cell Titer961®Aqueous One, Promega,
Madison, WI, USA) was used for metabolic activity testing purposes. The optical density was measured
(Labsystem Multiskan MS, Vantaa, Finland) at 492 nm and 620 nm as the reference. The corresponding
blanks were subtracted and the data was presented as a percentage of the control values (untreated cells).
In the case of the THP-1 suspension (monocytes), the cells were seeded on 96-well U bottom plate
at a concentration of 10,000 cells/cm2 in 90 µL of medium supplemented with 5% FBS and with no FBS
supplementation. Subsequently, 10 µL of NPs diluted in the corresponding medium were added so
as to attain final concentrations of 25, 50, and 100 µg/mL. The cells were incubated in a humidified
CO2 incubator at 37 ◦C on a shaker. After 6 h, the appropriate amount of FBS was added to the
non-supplemented wells (non-standard conditions) so as to attain a final concentration of 5% FBS, and
the shaker was switched off. With respect to the MTS measurement, the plates were centrifuged (210 g,
5 min, RT) and 50 µL of the supernatant was aspirated and stored in a freezer for further processing
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(cytokine detection assay). 50 µL of 20% MTS solution in 5% RPMI was then added so as to attain a
final concentration of 10% MTS in the sample. The cells were slightly resuspended and incubated for
2 h in the humidified CO2 incubator at 37 ◦C. The optical density was measured as described above.
2.5. Flow Cytometry Determination of the Cell Number, Mitochondrial Mass, and Potential
The suspension THP-1 cells were cultured and treated as described above with a volume of 250 µL
(8250 cells/well) for the cell number analysis. The 96-well U bottom plate was transferred after the
desired incubation time to a flow cytometer (BD FACS Canto, Franklin Lakes, NJ, USA) and the total
cell count in a volume of 50 µL was calculated.
The cells were cultured in 6-well plates at a concentration of 10,000 cells/cm2 (without FBS
supplementation) with 100 µg/mL of NPs for the detection of the mitochondrial mass and potential.
The cells were incubated in the humidified CO2 incubator at 37 ◦C on a shaker. After 6 h, the appropriate
amount of FBS was added so as to attain a final concentration of 5% FBS, and the shaker was switched
off; cultivation continued up to 24 h. The cells were then transferred to FACS tubes and stained using
MitoTracker™ probes. The mitochondrial mass was detected using MitoTracker™ Green FM (M7514,
Invitrogen, Carlsbad, CA, USA) and the mitochondrial potential using MitoTracker™ Red FM (M22425,
Invitrogen, Carlsbad, CA, USA). The incubation time of the cells with both probes was 30 min in the
humidified CO2 incubator. The positive control (cells with an uncoupled mitochondrial membrane
potential) was first treated with 1 mM of carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone
(FCCP, Sigma Aldrich, St. Louis, MO, USA) in the cultivation medium for 30 min in the humidified CO2
incubator at 37 ◦C and then stained employing the aforementioned procedure. The stained samples
were analyzed using flow cytometry (BD FACS Canto, 20,000 cells per sample). The data obtained
were processed via FlowJo software (FlowJo LLC, version 10.6.1, Franklin Lakes, NJ, USA ).
2.6. Histological Staining for the Morphological Analysis
The suspension THP-1 cells were seeded at a concentration of 10,000 cells/cm2 in 6-well dishes in
RPMI medium with 5% FBS containing 100 µg/mL of particles. The cells were cultured for 4 days,
whereupon 0.5 ml of RPMI medium with 50% FBS was added so as to provide sufficient nutrients.
The cultivation proceeded for other 3 days. Then the cells remaining in the suspension were spun
(300 g, 10 min, RT) and the adherent cells harvested using a standard procedure. All the acquired
cells were mixed together, spun (300 g, 10 min, RT) and resuspended in PBS. An approximately 10 µL
drop of cell suspension was smeared on a glass slide and allowed to dry. The slides were then fixed
in methanol (5 min, RT) and stained employing May–Gründwald–Giemsa–Romanowski staining.
The slides were analyzed by means of light microscopy (Olympus IX71, Tokio, Japan) with a color
camera (Olympus DP74, 100x UPlanPI objective with oil immersion, Tokio, Japan).
2.7. Cytokine Detection
Supernatants from the metabolic activity tests were used for cytokine detection purposes.
The positive control (monocytes stimulated to inflammation) involved the treatment of the cells with
lipopolysaccharide (LPS, 50 µg/mL, E. Coli O111:B4, Sigma-Aldrich, St. Louis, MO, USA) in the same
manner as the NP-treated cells. A Human Cytokine Antibody Array (ab133997, Abcam, Cambridge,
United Kingdom) was used according to the manufacturer’s manual. The chemiluminescence data
was acquired using the ChemiDoc MP (BioRad) system and the data was processed using ImageLab
software (BioRad, version 6.0.1., Hercules, CA, USA). The data were normalized and expressed as a
percentage of the untreated control.
2.8. Statistical Analysis
All the data were presented in the form of the means of all the experimental values related
to the control from three biologically independent experiments running in duplicate (at least) with
error bars representing the standard deviations. The data were statistically processed using Statistica
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software (StatSoft Inc., version 12, Tulsa, OK, USA). Remote and outlier values were subtracted based
on box graph visualization. The statistical significance against the control was calculated using the
non-parametric Wilcoxon matched-pairs test with p-values of 0.05 and less.
3. Results
3.1. Nanoparticle Preparation and Characterization
The preparation of SiC–x and SiC–OH NPs has been reported previously [32–34]. SiC–NH2 NPs
were prepared from SiC–OH NPs via silanization as described in Materials and Methods. Figure 1A
shows the infrared spectra of all the SiC-based NPs. In the case of the SiC–x NPs, the majority of the
surface groups are carboxyl groups (COOH). Following the elimination of the carboxyl groups using
NaBH4, reduction is clearly visible from the disappearance of the peak at 1724 cm–1, and the shift
and shrinkage of the OH related peak at around 3000 cm–1 renders the surface hydroxyl terminated
(blue curve—SiC–NH2). The presence of 3-aminopropyl(diethoxy)methylsilane (APDMES) used
for the preparation of the SiC–NH2 enhances the C–O–Si related peak at around 1040 cm–1. New
peaks appear due to the presence of C-C, C-H and N-H bonds at around 1400–1500, 2800–300, and
1550–1650 cm–1, respectively.
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Figure 1. Characterization of the SiC-based NPs. The FTIR spectra (A) and size distribution (C) of the
SiC-based NPs with differing surface terminations based on AFM measurement of individual NPs
height. The NMR spectra of APDMES and SiC–NH2 (B).
Nuclear magnetic resonance (NMR) also indicated the presence of APDMES (Figure 1C).
The disappear nce of the detectable ethoxy par indica es that all the APDMES hydrolyzed during the
reaction, and the lack f the existence of Si–OH groups indicates that t APDMES is l nked to the
surface. Hydrolyz d but non-linked APDMES has an Si–OH group that was detectable nly in the
co trol, i.e., no in the SiC–NH2 NP sa ple, thus indicating successful surface modification.
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Atomic force microscopy (AFM, over 300 particles for each particle type) measurements revealed
that the height of SiC-based NPs was under 5 nm (Figure 1B). No significant changes were observed
following surface modification, with the exception that the mean size shifted slightly from 1.5 nm to
1.7 and 1.8 nm for the SiC–OH and SiC–NH2 respectively, which was caused by a certain degree of
aggregation. Nevertheless, the mean sizes of the SiC-based NPs applied in this study were 1.5 nm,
1.7 nm, and 1.8 nm for the SiC–x, SiC–OH, and SiC–NH2 NPs respectively.
3.2. Determination of Zeta Potential in Different Solutions
The behavior of NPs is closely related to their zeta potential (ζ), which reflects the stability of the
colloidal suspension of the NPs. By approaching parameter ζ to 0 mV, the colloidal stability worsens,
as the NPs attract each other and agglomerate. The NPs used herein were prepared as a stock solution
in water and the influence of the biomolecules that originated from the cell cultivation media on the ζ
was assessed. Thus, Dulbecco’s modified Eagle medium (DMEM) (experimental cultivation medium
for osteoblasts) and RPMI 1640 medium (a standard cultivation medium for monocytes/macrophages)
were used as appropriate solutions for the estimation of ζ under biological conditions—in particular
cases supplemented with FBS. All the NP types in water exhibited approximately the same ζ, i.e.
around −35 mV (Figure 2). The transfer of NPs into the cell cultivation media shifted the ζ to around
-45 mV. Parameter ζ decreased only for the SiC–OH NPs in the RPMI medium that evinced into low
colloidal stability. The value of ζ of the SiC–x NPs in the DMEM medium is not presented since
the SiC–x NPs evinced such a high surface charge (ζ of higher than ±50mV) that they could not be
centrifuged out and analyzed. The media supplemented with 5% FBS resulted in a shift in the ζ back
to approximately -30 mV, which is considered to be the colloidal stability level [35,36].Nanomaterials 2020, 10, x FOR PEER REVIEW 7 of 18 
7 
 
 
 
Figure 2. Value of ζ for the SiC-based NPs in different solutions. Parameter ζ was measured on NPs 
in water, DMEM and RPMI 1640 with and without the addition of 5% FBS. 
3.3. Metabolic Activity of the Different Cells Following NP Treatment 
The metabolic activity of the different cells (human osteoblasts—SAOS-2; and 
monocyte/macrophages—THP-1) following their exposure to SiC-based NPs was measured using 
the MTS test under standard (5% FBS in the medium from the outset) and non-standard (no FBS in 
the medium for the first 6 h followed by incubation in the medium supplemented with 5% FBS) 
conditions. 
Figure 3A shows that the metabolic activity of a well-described and established osteoblastic cell 
line under standard conditions was not affected by any of the concentrations and types of NPs used. 
The metabolic activity was approximately at the same level as the control (untreated) cells in all cases. 
In the case of non-standard conditions (Figure 3B), the metabolic activity after 6 h was comparable to 
that under standard cultivation conditions. However, after 24 h of incubation, the cellular metabolic 
activity of the SiC–NH2 and SiC–OH NPs at higher concentrations increased significantly.  
The human monocytic cell line—THP-1—was cultivated in two forms, i.e. as a suspension of 
monocytes and as substrate-adherent macrophage-like cells. Both these types of immune cells were 
tested for their metabolic activity following the administration of the differing SiC-based NPs.  
In the case of tissue-specific, macrophage-like cells, the obvious effect of FBS medium 
supplementation was observed. Within the first 6 h of incubation under standard conditions, none of 
the NPs (with PCs) significantly affected the cellular metabolic activity (Figure 3C). A visible 
cytotoxic effect (metabolic activity under 75% of the control [37]) was observed later (after 24 h of 
incubation) with respect only to the two highest SiC–x NP concentrations. Under non-standard 
conditions (bare NPs), the metabolic activity was significantly reduced after 6 h by all the NP types 
and concentrations (Figure 3D). Moreover, all the NPs had attained the cytotoxic level at this time 
point at the highest concentration applied. After 24 h of incubation, substantial differences were 
observed between the differing NP types. After 6 h, the negative impact of the SiC–NH2 NPs on the 
cells was insignificant; these NPs appeared to be harmless. Conversely, the SiC–x and SiC–OH NPs 
were significantly cytotoxic with the effect being dose-dependent.  
With respect to the monocytes under the standard cultivation conditions (Figure 3E), after 6 h 
most of the NPs had not induced any changes in the cell metabolic activity, with two exceptions. The 
SiC–OH NPs at the highest concentration reduced the metabolic activity to the cytotoxic level and 
the SiC–x NPs at the lowest concentration significantly increased the metabolic activity of the 
Figure 2. Value of ζ for the SiC-based NPs in different solutions. Parameter ζ was measured on NPs in
water, DMEM and RPMI 1640 with and without the addition of 5% FBS.
3.3. Metabolic Activity of the Different Cells Following NP Treatment
The metabolic activity of the different cells (human osteoblasts—SAOS-2; and monocyte/macrophages
—THP-1) following their exposure to SiC-based NPs was measured using the MTS test under standard
(5% FBS in the medium from the outset) and non-standard (no FBS in the medium for the first 6 h
followed by incubation in the medium supplemented with 5% FBS) conditions.
Figure 3A shows that the metabolic activity of a well-described and established osteoblastic cell
line under standard conditions was not affected by any of the concentrations and types of NPs used.
The metabolic activity was approximately at the same level as the control (untreated) cells in all cases.
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In the case of non-standard conditions (Figure 3B), the metabolic activity after 6 h was comparable to
that under standard cultivation conditions. However, after 24 h of incubation, the cellular metabolic
activity of the SiC–NH2 and SiC–OH NPs at higher concentrations increased significantly.
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The human monocytic cell line—THP-1—was cultivated in two forms, i.e., as a suspension of
monocytes and as substrate-adherent macrophage-like cells. Both these types of immune cells were
tested for their metabolic activity following the administration of the differing SiC-based NPs.
In the case of tissue-specific, macrophage-like cells, the obvious effect of FBS medium supplementation
was observed. Within the first 6 h of incubation under standard conditions, none of the NPs (with PCs)
significantly affected the cellular metabolic activity (Figure 3C). A visible cytotoxic effect (metabolic
activity under 75% of the control [37]) was observed later (after 24 h of incubation) with respect only to
the two highest SiC–x NP concentrations. Under non-standard conditions (bare NPs), the metabolic
activity was significantly reduced after 6 h by all the NP types and concentrations (Figure 3D). Moreover,
all the NPs had attained the cytotoxic level at this time point at the highest concentration applied. After
24 h of incubation, substantial differences were observed between the differing NP types. After 6 h, the
negative impact of the SiC–NH2 NPs on the cells was insignificant; these NPs appeared to be harmless.
Conversely, the SiC–x and SiC–OH NPs were significantly cytotoxic with the effect being dose-dependent.
With respect to the monocytes under the standard cultivation conditions (Figure 3E), after 6 h most
of the NPs had not induced any changes in the cell metabolic activity, with two exceptions. The SiC–OH
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NPs at the highest concentration reduced the metabolic activity to the cytotoxic level and the SiC–x NPs
at the lowest concentration significantly increased the metabolic activity of the monocytes. After 24 h,
the SiC–x NPs at the highest concentration reduced the monocytic metabolic activity to the cytotoxic
level. The metabolic activity of the cells treated with SiC–OH NPs remained at or returned to the level
of the untreated control cells. However, the SiC–NH2 NPs markedly increased the metabolic activity of
the monocytes (to around 200% of the control) after 24 h. Under non-standard conditions (Figure 3F),
the metabolic activity was slightly reduced in all the cases after 6 h; however, after 24 h the situation
was similar to that of the standard cultivation conditions. Again, the only cytotoxic NPs consisted
of the SiC–x NPs at the highest concentration applied, whereas the SiC–OH NPs were at the level of
the control cells and the SiC–NH2 treated cells again, surprisingly, doubled their metabolic activity
compared to the control.
The tested NPs induced such significant differences in the metabolic activity of the suspension
monocytes that further experiments were initiated focusing on these cells as treated with the highest
applied NP concentration under non-standard cultivation conditions for 24 h.
3.4. Cell Number, Mitochondrial Mass, and Mitochondrial Potential
On that account these monocytes were further characterized with respect to the cell number
(Figure 4B), mitochondrial mass (Figure 4C) and mitochondrial potential (Figure 4D) because each of
them can influence the metabolic activity determined by used method (MTS assay). This method is
based on the conversion of a tetrazolium compound to a colored formazan product which is presumably
accomplished by NADPH or NADH produced by dehydrogenase enzymes in metabolically active
cells. These dehydrogenases are located in mitochondria as well as in cytosol. In spite of their differing
metabolic activities (Figure 4A), the number of monocytes was comparable following treatment with
differently-terminated SiC-based NPs (Figure 4B). Even though the SiC–x NP treated cells demonstrated
a statistically significant decrease in their number (to 95% of the control cells), it did not reflect the
significant decrease in their metabolic activity (to 50% of the control cells) (Figure 4A).
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In order to monitor the role of mitochondria in the increased metabolic activity, the overall
mitochondrial mass and membrane potential were evaluated using flow cytometry. Figure 4C shows
no significant differences in the mitochondrial mass (determined using a fluorescent probe independent
of the mitochondrial potential) observed for the cells treated with all three types of NPs tested over 24 h.
The determination of the mitochondrial membrane potential was conducted in the same manner as that
of the detection of the mitochondrial mass; however, the probe accumulation in mitochondria is highly
dependent on their membrane potential as confirmed via FCCP, which was used as an uncoupling
agent. As shown in Figure 4D, the SiC–x NPs significantly decreased the mitochondrial potential of
the monocytes. Surprisingly, the same phenomenon was also observed in the cells incubated with
SiC–NH2 particles whose metabolic activity (Figure 4A) was particularly high. The SiC–OH NP treated
cells evinced a non-significant decrease in their mitochondrial potential that was comparable to the
untreated control.
3.5. Cytokine Release from the Monocytes Following Treatment with Differing SiC-Based NPs
Cytokines play a key role in cell signaling and this role is even more important in the immune
system in terms of mediating its response to different irritating agents. A broad panel of 42 cytokines
was tested in order to determine the most important molecules related to the effect of SiC-based NPs
on monocytes. Following normalization to the NP untreated control, various cytokine profiles induced
by differently-terminated SiC-based NPs were detected (Figure 5). The release of all the detected
cytokine types from the cells treated with SiC–x NPs was generally lower than those treated with
SiC–NH2 and SiC–OH NPs. The pro-inflammatory cytokine interleukin 8 (IL-8) was the only cytokine
released at a significant level by the SiC–x NP stimulated cells. High levels of IL-8 were also detected
in the cells treated with other types of NPs. Moreover, treatment with SiC–NH2 and SiC–OH NPs
induced a significant increase in a variety of cytokines such as pro-inflammatory MCP-1, RANTES,
and IL-1β and pro-mitogenic GRO-α compared to the untreated control and the cells treated with
SiC–x NPs. All of these cytokines were also produced by the positive control cells (cells treated with
lipopolysaccharide—LPS), but at an elevated level.
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Figure 5. Cytokines detected in the supernatant from the suspension THP-1 monocytes. Cells were
treated with 100µg/mL of SiC-based NPs or LPS under non-standard conditions. After 24 h of incubation,
cell supernatant was harvested and analyzed for the presence of a broad panel of cytokines. The data
was normalized and is presented as a percentage of the untreated control supernatant levels. The error
bars show standard deviation. The dashed line shows 100% of the untreated control.
3.6. Morphological Changes in the Cells Following Long-Term Treatment with SiC-Based NPs
Since no change was observed in the monocyte morphology following short-term incubation
(24 h) with NPs of differing surfaces, the long term (7 days) influence of the various SiC-based NPs
(100µg/mL) on the monocytic cells was determined; Figure 6 shows the representative morphology of
the most commonly-found cells. The control monocytes (Figure 6D) were treated in the same way as the
other NP-treated cells (6 h incubation in FBS-free medium, the rest of the incubation time in the medium
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supplemented with 5% FBS). After 7 days, the cells demonstrated only slight changes in the cytoplasm
content compared to fresh THP-1 cells sub-cultured in the standard way (Figure 6F). More dramatic
changes were observed in all of the NP-treated cells. All of the SiC–x NP treated cells were found
to be dead and only cell debris could be observed (Figure 6A). Treatment with SiC–NH2 (Figure 6B)
induced an increase in the total number of cells (data not shown) compared to all the other samples,
and a significant number of adhered cells with a macrophage-like morphology similar to the cells that
were chemically-differentiated into macrophage-like cells (Figure 6G). However, a high number of cells
remained in suspension with a morphology similar to the control monocytes (Figure 6D). An interesting
mixture of morphology types was observed with respect to SiC–OH treatment (Figure 6C1-3). While a
portion of the cells revealed a macrophage-like morphology (Figure 6C3) as in the SiC–NH2 treated
cells (Figure 6B), some of the cells also acquired a dendritic cell-like morphology (Figure 6C1) similar
to the cells that chemically-differentiated into dendritic-like cells (Figure 6E). The remaining cells were
either dead (only a small number) or resembled fresh THP-1 cells (Figure 6C2).
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Figure 6. Microscopic analysis of the morphological changes on the THP-1. Representative images of
the monocytic THP-1 cells after 7 days of incubation with 100 µg/mL SiC–x NPs (A), SiC–NH2 (B) and
SiC–OH (C1—dendritic cell-like; C2—monocytic; and C3—macrophage-like). Control cells (monocytes,
incubated in the same manner as the NP-treated cells (10,000 cells/cm2) (D), chemically-differentiated
monocytes to dendritic-like cell morphology (E), monocytes (kept in the culture – 133 000 cells/cm2)
(F), and chemically-differentiated macrophage-like cells (PMA treatment) (G). All the images were
captured at 100× magnification; the scale bar represents 10 µm.
4. Discussion
It is known that the majority of particles tend to change their ζ following the transition into
biological fluids [38,39]. Even though amine-terminated surfaces usually have positive zeta potential
in salt-free solutions and acidic pH, the data presented herein showed highly negative ζ in case of
SiC–NH2 NPs. This could be explained by incomplete functionalization of the NP surface. SiC-based
NPs are rich in surface groups as one can see in the FTIR spectra (Figure 1A). The overall zeta potential
is determined by the salinity and counterions in the solution, the pH, and the surface chemistry.
Among the amine groups, SiC–NH2 NPs surface likely contains unreacted hydroxyl and silanol groups,
and C=C double bonds. This influences the surface potential because of the small distance between
particular hydroxyl groups [33], sterical hindrance is expected. The SiC-based NPs presented herein
proved to be fully dispersed both in water and in the cultivation medium even when supplemented with
FBS, which suggests that the particles remained in the colloid and thus were able to interact with the
cells as individual entities. However, a negative ζ may prevent direct contact with a negatively-charged
cellular membrane. Nevertheless, the effect induced by the SiC-based NPs on the various cells is
apparent, thus indicating the existence of interaction. Moreover, other research has pointed out
the potential for NP-cell interaction under such conditions [40–42]. The only exception where the ζ
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was shifted to a surface charge range that favored cluster formation involved the SiC–OH particles
incubated in the RPMI 1640 medium. This shift was not observed for the DMEM medium and, from
the simple comparison of the media composition, it was not possible to determine a clear link. Some
ingredients were presented at strikingly different concentrations (e.g., sodium phosphate monobasic in
the RPMI compared to the DMEM (800 mg/l and 125 mg/l respectively)), which may have been the
reason for such a change. The dramatic drop in the ζ potential of the SiC–OH NPs (to -17 mV) in the
RPMI medium was restored to the ζ corresponding to the stable colloidal solution when the NPs were
incubated in the RPMI medium supplemented with FBS. Thus, in this case, the FBS inhibited aggregate
formation. The aggregation preventive properties of FBS have already been described by Balek et al.
concerning nanodiamonds [43].
The concentration gradient of the NPs used herein was based on our previous research on
different types of ultra-small silicon-based NPs [42,44]. In both of these studies, said concentration
gradients proved to have an impact on metabolic activity of osteoblastic cell line (SAOS-2). Surprisingly,
the results showed that irrespective of the NP surface termination, concentration, and cultivation
conditions, none of the SiC-based NPs exerted a significant effect on the metabolic activity of these
cells in the short-term experiment (24 h). In context of further results presented herein, it seems that
used doses of NPs are inert in respect of osteoblasts but cause response in much more responsive cells
such as immune cells. Furthermore, the slight elevation in the metabolic activity of the osteoblasts
treated with SiC–NH2 and SiC–OH after 24 h of incubation indicated possible cell–NP interactions
with potentially longer manifestation times.
The same NPs were also tested with respect to tissue-specific immune cells (adherent THP-1
cells, sometimes referred to as macrophage-like cells). In this case, the initial FBS supplementation
of the cultivation medium and, thus, the immediate formation of PCs on the NPs, proved to be
the overall key factor that protected the cells from an NP-induced decrease in metabolic activity.
This finding corresponds with the previously reported cell-protective impact of protein adsorption
onto NPs [20,21,29]. However, this protective effect was not sufficient to prevent a decrease in the
metabolic activity of the cells treated with the two highest SiC–x NP concentrations after 24 h. Under
non-standard cultivation conditions, the bare NPs (without PCs) initiated a significant decrease in the
metabolic activity of these cells after a short incubation period. However, following the removal of
the medium containing the NPs and its replacement with a fresh FBS-containing medium (at the 6 h
time point), the effect of the SiC–NH2 NPs was neutralized and the cell activity was restored to the
level of the untreated cells. A similar protective effect of PC was observed in the cells treated with
the lowest concentration of SiC–x NPs. Moreover, the higher SiC–x NP concentration accentuated the
harmful effect of these NPs, which could have meant that the SiC–x NPs induced irreversible harm
to the cells within the first 6 h of incubation, while the SiC–NH2 NPs were less harmful and may
have initiated apoptotic rescue mechanisms [45]. This observed phenomenon implies that a certain
critical concentration of SiC–x and SiC–NH2 NPs exists and that, within the first 6 h, it exerts a decisive
influence on the fate of cells. The same situation did not apply, however, in the case of the SiC–OH NPs,
where an ongoing concentration-dependent toxic effect was observed even after the NP-containing
medium had been discarded. In this case, the SiC–OH NPs in the RPMI medium without FBS exhibited
the ζ of -17 mV, thus rendering them prone to NP aggregation. Such aggregates cannot be dissolved
via the simple addition of FBS and, moreover, are prone to sedimentation. These aggregated sediments
cannot easily be discarded in the same manner as the non-clustered particles (SiC–x and SiC–NH2
NPs) which remained in the colloid. Thus, SiC–OH NPs may exert an ongoing negative impact on
cellular metabolism which may be caused, for example, by the simple mechanical blocking of the
membrane due to the quantity of NP clusters, thus resulting in the occurrence of harmful changes in
the cellular membrane phase (i.e., gelation) [46]. Since the ζ of the SiC–OH NPs in the RPMI medium
supplemented with FBS was -41 mV, the NPs most probably remained in the colloid and exerted no
impact on the cellular metabolism. The statistical significances are not presented since they were not
considered to be biologically relevant.
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Furthermore, when the NPs were tested with respect to monocytic cells, the protective properties
of FBS supplementation were also observed; however, the surface termination of the NPs proved
to be highly important. In this case, slightly different cultivation conditions were applied (the NPs
remained in the incubation medium throughout the whole of the experiment) since the cultivation
of suspension cells requires a different approach. The SiC–x NPs demonstrated a similar effect on
cellular metabolism under both standard and non-standard conditions. The SiC–NH2 NPs proved
to be harmless under standard conditions (FBS supplemented) within the first 6 h of incubation and,
interestingly, longer cultivation times led to a significant increase in the metabolic activity. Under
non-standard conditions, the observed impact of the SiC–NH2 NPs on the cellular metabolism was
similar to that seen previously with the macrophage-like THP-1. The potential rescue from apoptosis
discussed previously concerning these particles manifested itself to a remarkable extent. The SiC–OH
NPs exhibited strong FBS-supplementation dependence with regard to their cytotoxic abilities. Under
standard cultivation conditions, the monocytic cells responded in the same manner as macrophage-like
cells, the explanation for which could be the same as for the previously-described macrophage-like
cells, despite monocytic THP-1 cells being non-adherent. As such, the monocytes may have come into
contact with the clustered SiC–OH NPs only within the first 6 h since the plate was incubated on a
shaker so as to prevent sedimentation. After this time point, the shaker was switched off and, most
probably, the clusters so formed sedimented, while the cells remained in suspension and subsequently
encountered the NPs. The 24-hour time point confirmed the enormous impact of surface termination
on the NP-cell interaction as previously reported [47,48]. This phenomenon was clearly observed
particularly under non-standard conditions with the highest concentration of NPs applied.
The MTS assay employed is commonly considered a reflection of the cellular mitochondria
function due to the principle thereof (the reduction of the tetrazolium compound into formazan
via cellular NAD(P)H dehydrogenase), i.e., the dehydrogenases are most commonly found in the
mitochondria. Even though the results of the MTS test suggested that the cellular metabolism differs
significantly depending on the type of NP, the other results obtained demonstrated that after 24 h of
incubation, the cells treated with all three types of NPs exhibited approximately the same mitochondrial
mass. Significant and unexpected changes were, however, identified with respect to the mitochondrial
potential. The SiC–NH2 NP-treated cells evinced approximately the same mitochondrial potential
as the SiC–x NP-treated cells with completely the opposite metabolic activity detected. As some
researchers have pointed out, while the MTS and MTT assays do not necessarily exclusively reflect
the mitochondrial NAD(P)H dehydrogenase activity, the other dehydrogenases participate in the
chemical reaction to a far lower extent [49,50]. This could indicate that the SiC–NH2 NP treatment
led to the switching of the cellular metabolism, most probably from oxidative phosphorylation to
glycolysis, concerning which glyceraldehyde 3-phosphate dehydrogenase may have performed the
reduction of tetrazolium salt observed via the MTS assay. This switch may, in turn, indicate that the
SiC–NH2-stimulated monocytes were directed towards differentiation into activated M1 macrophages,
which are known to produce ATP primarily from glycolysis since oxidative phosphorylation is used as
an ROS producer to efficiently kill bacteria [51,52].
Since different reactions were observed between the monocytic cells and the various SiC-based NPs
tested, it was clear that their reaction with respect to cytokine release should be examined. There is no
information in the literature regarding cytokine production following cell stimulation with ultra-small
SiC-based NPs, therefore a broader overview was considered necessary. Thus, a panel of 42 cytokines
was tested in order to simply and qualitatively determine the presence of certain cytokines. It is common
for any foreign material to induce an inflammatory response from immune cells since the surface identity
does not usually resemble any naturally-occurring component. A number of studies have reported
the production of inflammatory cytokines such as IL-6, IL-1β, and TNF-α related to the nanoparticle
treatment of cells [53–55]. The results demonstrated that while all the tested SiC-based NPs induced
inflammation to a certain extent, the effect was not as strong as in the positive control (LPS treatment).
The observed inflammatory pattern suggests that monocytic THP-1 cells respond and interact with
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all types of SiC-based NPs. Moreover, the production of classical pro-inflammatory cytokines, such
as IL-1β and TNF-α, supports the potential for M1 macrophage differentiation and polarization since
such cytokines are commonly connected to these cells. In addition, the other cytokine species observed
at higher levels such as RANTES, IL-8, and MCP-1 indicated that NPs activate monocytes and act as
pro-inflammatory agents. Particularly high levels of IL-8 were observed, thus suggesting that these
NPs could potentially lead to a granulocytic immune cell response which is known to be one of their
most common functions in vivo. IL-8 has also been demonstrated to act as an angiogenesis mediator
by inducing chemotactic and proliferative activity in endothelial cells [56]. The presence of IL-8 and
MCP-1, however, should be of concern since the combination of these two cytokines is known to attract
neutrophils and to promote inflammation. Fortunately, no allergic response (increased levels of IL 4,
5, and 13) was detected via the application of the tested NPs; their presence would have prevented
the future use of such NPs in vivo since a strong allergic reaction could result in fatal consequences
(e.g., anaphylactic shock in living organisms). Increased attention is being devoted to the role of NPs
in the development of new allergies, which is increasingly becoming a subject of concern in human
medicine [26,57]. The non-presence of pro-allergic cytokines produced by monocytic THP-1 cells in
response to SiC-based NP treatment is thus desirable and indicates that this nanomaterial is harmless in
this respect; however, significant concerns with respect to acute inflammation have been raised by high
levels of IL-8 and MCP-1. These cytokines also present promising application potential concerning their
positive influence on neutrophils. The fact that monocytic cells interact with nanoparticles, while not
becoming over-activated, identifies these SiC-based NPs as a potential immunomodulatory material.
Practically no long-term studies of the influence and differentiation abilities of NPs have been
conducted to date. in vivo, monocytes possess the ability to differentiate into macrophages or dendritic
cells dependent on the needs of the immune system. Since various pro-inflammatory cytokines were
detected after 24 h of incubation with the particles, the possible impact on changes in the cellular
morphology were studied after a longer period (7 days). The cells cultured with SiC–NH2 and SiC–OH
NPs evinced significant changes in their morphology, thus suggesting the application potential of these
NPs as immunomodulatory material. Since most of the cells treated with SiC–NH2 particles were
transformed into adherent macrophage-like cells and the SiC–OH NPs provided cells that differentiated
into macrophage-like and dendritic cell–like morphologies, both of these particles might potentially
be employed as ex vivo stimuli for immune cell therapy via long-term treatment as well as for the
stimulation (again, ex vivo) of the immune response in immunodeficient individuals. This ex vivo
application has been proposed with respect to various silicon-based NPs [54,58]. However, in the case
of the SiC–NH2 NPs, further attention should be devoted to the observed increase in the cell count
(not published), which could indicate the mean overstimulation of the cells and could possibly lead
to an undesirable excessive response. Consequently, SiC–OH NPs might be considered eligible for
further ex vivo application as suggested since, although the number of cells did not differ from the
control, differentiation was present. Morphological changes were also observed in the control cells that
were treated in the same manner as the NP-treated samples. While the cells remained in suspension,
they evinced a markedly higher amount of cytoplasm. This change was most probably caused by the
suboptimal cultivation conditions (i.e., low cell density) that were applied so as to retain the same
conditions as those of the NP-treated cells. Another possible explanation is that standard cultivation
(high cell density) was conducted in the medium supplemented with heat inactivated FBS (i.e., inactive
complement), while the particle-related experiments (cultivation in low cell density) were conducted
in the medium with FBS without heat inactivation (i.e., active complement).
All the aforementioned potential applications must, however, be further tested on primary cells
from human donors. The ex vivo stimulation of cells and the subsequent return of such cells into
the body presents a further direction for immunomodulation research. Cells stimulated in this way
could produce cytokines that positively influence the number and activity of neutrophils, which offers
potential with concern to neutrophil-related immunodeficiencies [59].
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5. Conclusions
Even though different termination of SiC-based NPs does not have a significant effect on their
colloidal stability in the cultivation media, it plays a key role in respect to human cells. Monocytes,
being a key part of the immune system, produce a variety of cytokines upon contact with these NPs
and mark them as a potential immunomodulatory material. Further research regarding changes in
metabolic pathways, differentiation capabilities and cytokine productions were however of major
interest in order to correctly establish the application potential of these NPs.
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